Search

Author/Creator Hanrott, Kate

1. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). Issue 2 (2nd February 2023)

Authors:
Patel, Jatin; Bass, Damon; Beishuizen, Albertus; Bocca Ruiz, Xavier; Boughanmi, Hatem; Cahn, Anthony; Colombo, Hugo; Criner, Gerard J.; Davy, Katherine; de-Miguel-Díez, Javier; Doreski, Pablo A.; Fernandes, Sofia; François, Bruno; Gupta, Anubha; Hanrott, Kate; Hatlen, Timothy; Inman, Dave; Isaacs...
Journal:
European respiratory journal
Issue:
Volume 61:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension. (20th January 2022)

Authors:
Simon, Marc A.; Hanrott, Kate; Budd, David C.; Torres, Fernando; Grünig, Ekkehard; Escribano‐Subias, Pilar; Meseguer, Manuel L.; Halank, Michael; Opitz, Christian; Hall, David A.; Hewens, Deborah; Powley, William M.; Siederer, Sarah; Bayliffe, Andrew; Lazaar, Aili L.; Cahn, Anthony; Rosenkranz, S...
Journal:
Pulmonary circulation
Issue:
Volume 12:Number 1(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search